Contact Us   |   Sign In   |   Join
Treatment, Vaccines and Diagnostics



FDA Nears Decision Authorizing Covid-19 Treatment With Convalescent Plasma


At White House Roundtable, Paul Perreault Urges People to Donate Plasma in the Fight Against COVID-19


Johnson & Johnson COVID-19 vaccine provided protection in monkeys


Two coronavirus vaccines begin the last phase of testing: 30,000-person trials


MRIGlobal works with animal vaccine company on human Covid-19 vaccine

Wash U, SLU will begin Covid-19 vaccine trials

Moderna gets further $472 million U.S. award for coronavirus vaccine development


U.S. to pay Pfizer, BioNTech $1.95 billion for COVID-19 vaccine


Lab-made virus mimics COVID-19 virus


Pfizer and BioNTech receive FDA Fast Track designation for investigational COVID-19 vaccine candidates


Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end: WSJ


Coronavirus vaccine progress: Moderna partners for manufacturing deal, more trials to start soon


KC-tested experimental Covid-19 vaccine moving to Warp Speed after positive study results


Researchers Look Far, Wide for 120K Vaccine Subjects

Johnson & Johnson Prepares For COVID-19 Vaccine Human Trials


MRIGlobal Awarded Grant To Fund COVID-19 Laboratory Training On The African Continent

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2


Effort to screen potential COVID-19 antiviral drugs underway


UMKC Receives First Federal Research Support to Directly Combat COVID-19



Covid-19 vaccine | Oxford vaccine most advanced, says WHO; Sanofi accelerates trials


Coronavirus vaccine candidates to begin final round of testing this summer


St. Louis biotech firm reaches key milestone with Covid-19 treatment

Sanofi Eyes Approval of COVID-19 Vaccine by First Half of 2021


Sanofi expands US vaccine venture in COVID-19 race


Gilead to start trial of inhaled version of Covid-fighting remdesivir


Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines


COVID-19 antibody tests evaluated as diagnostic test in low-resource settings


PeptiDream and Merck partner to develop Covid-19 therapeutics


Eli Lilly's CSO Thinks COVID-19 Antibody Treatment Could Be Ready by Fall 2020


Human trials for Johnson & Johnson coronavirus vaccine to start earlier than expected


COVID-19 mouse model will speed search for drugs, vaccines


Patients with COVID-19 donate specimens to advance research efforts


White House Works With Seven Drugmakers in ‘Warp Speed’ Push



Potential Covid Vaccine Speeds Growth at Catalent


SAB Biotherapeutics Confirms Neutralizing Antibodies to SARS-CoV-2 and Begins Clinical Manufacturing of Novel

COVID-19 Therapeutic Candidate


Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801


AVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2


Merck to Apply its Industry-Leading Vaccine Development Capabilities to SARS-CoV-2 Vaccine Program Originated by

Themis and Institut Pasteur


Merck to Announce Multiple Scientific Efforts to Combat COVID-19


Contract for Covid-19 testing component will bring expansion, 300 jobs to Lenexa


COVID-19 study looks at genetics of healthy people who develop severe illness


MU researcher identifies four possible treatments for COVID-19


Global study to test malaria drug to protect health workers from COVID-19

Takeda, CSL-led alliance and NIH to test COVID-19 plasma treatment this summer


MRIGlobal To Deliver Three Mobile Medical Labs For Department Of Defense


Pfizer producing new Covid-19 vaccine for clinical trials at St. Louis County facility


Pfizer and BioNTECH dose first participants in the U.S. as part of global COVID-19 mRNA vaccine development program


Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy


US allows use of 1st drug shown to help virus recovery




We need more covid-19 tests. We propose a ‘shark tank’ to get us there.


FDA allows Novartis to test hydroxychloroquine against COVID-19


NIH partners with 16 drug companies in hopes of accelerating Covid-19 treatments and vaccines


The race for antibodies


Pfizer Advances Battle Against COVID-19 on Multiple Fronts


Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19


Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19


Johnson & Johnson and Award-Winning Journalist Lisa Ling Explore What It Takes to End a Pandemic


Possible COVID-19 treatment: transfusion of antibodies from recovered patients’ blood


Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy


Area biotech works on treatment for lungs of COVID-19 patients


J&J picks top coronavirus vaccine candidate; human tests to start in September


Wash U gets FDA clearance to test a century-old idea on critical COVID-19 patients


Meet the SLU department on the frontlines of coronavirus vaccine development

Association Management Software Powered by YourMembership  ::  Legal